Cargando…

Gambogic acid increases the sensitivity to paclitaxel in drug-resistant triple-negative breast cancer via the SHH signaling pathway

Paclitaxel is the most frequently used therapy regimen for triple-negative breast cancer (TNBC). However, chemoresistance frequently occurs, leading to enhanced failure rates of chemotherapy in TNBC; therefore, novel biological therapies are urgently needed. Gambogic acid (GA) has potent anticancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yonghui, Sui, Yana, Tao, Yinggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797991/ https://www.ncbi.nlm.nih.gov/pubmed/31545492 http://dx.doi.org/10.3892/mmr.2019.10697

Ejemplares similares

LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway
por: Sui, Xiaomei, et al.
Publicado: (2018)

A Gamboge Case
por: Biegler, J. A.
Publicado: (1887)

Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer
por: Wang, Shengpeng, et al.
Publicado: (2017)

Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells
por: Panayotopoulou, Effrosini G., et al.
Publicado: (2017)

Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs
por: Li, Meng, et al.
Publicado: (2022)

Antitumor activity of gambogic acid on NCI-H1993 xenografts via MET signaling pathway downregulation
por: LI, DONGLEI, et al.
Publicado: (2015)

Antitumor activity of gambogic acid on NCI-H1993 xenografts via MET signaling pathway downregulation
por: Li, Donglei, et al.
Publicado: (2021)

MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway
por: Yin, Shi, et al.
Publicado: (2018)

Bromodomain-containing protein 4 is critical for the antiproliferative and pro-apoptotic effects of gambogic acid in anaplastic thyroid cancer
por: Wang, Yonghui, et al.
Publicado: (2018)

Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
por: Chen, Tao, et al.
Publicado: (2012)

Gambogic Acid and Piperine Synergistically Induce Apoptosis in Human Cholangiocarcinoma Cell via Caspase and Mitochondria-Mediated Pathway
por: Yapasert, Rittibet, et al.
Publicado: (2022)

MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer
por: Liu, Xiaoping, et al.
Publicado: (2015)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
por: Wang, Meng, et al.
Publicado: (2021)

ISL1 regulates lung branching morphogenesis via Shh signaling pathway
por: Huang, Ruiqi, et al.
Publicado: (2023)

Gambogic acid reverses oxaliplatin resistance in colorectal cancer by increasing intracellular platinum levels
por: Wang, Qiang, et al.
Publicado: (2018)

SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
por: Carreno, G, et al.
Publicado: (2019)

A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer
por: Sang, Mang Mang, et al.
Publicado: (2018)

Knockdown of SERPINE1 reverses resistance of triple-negative breast cancer to paclitaxel via suppression of VEGFA
por: Zhang, Qian, et al.
Publicado: (2020)

Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells
por: Sezer, Gülay, et al.
Publicado: (2022)

A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
por: Liu, Yuetong, et al.
Publicado: (2023)

Positive and negative regulation of Shh signalling in vertebrate retinal development
por: Gallardo, Viviana, et al.
Publicado: (2018)

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
por: Ma, Dongjie, et al.
Publicado: (2018)

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway
por: Ma, Dongjie, et al.
Publicado: (2021)

Apoptotic effect of gambogic acid in esophageal squamous cell carcinoma cells via suppression of the NF-κB pathway
por: LIU, WEN-YUE, et al.
Publicado: (2016)

RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage
por: Haynes, Brittany M., et al.
Publicado: (2022)

Connexin 43 Modulates the Cellular Resistance to Paclitaxel via Targeting β-Tubulin in Triple-Negative Breast Cancer
por: Fu, Yun, et al.
Publicado: (2020)

Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid
por: Xu, Wei, et al.
Publicado: (2019)

Methylseleninic Acid Enhances Paclitaxel Efficacy for the Treatment of Triple-Negative Breast Cancer
por: Qi, Yanfeng, et al.
Publicado: (2012)

Aspirin inhibits the SHH/GLI1 signaling pathway and sensitizes malignant glioma cells to temozolomide therapy
por: Ming, Jianguang, et al.
Publicado: (2017)

Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer
por: Sun, Shanshan, et al.
Publicado: (2021)

Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer
por: Chen, Jing, et al.
Publicado: (2021)

Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment
por: Zhang, Zhen, et al.
Publicado: (2017)

Gambogic acid suppresses colon cancer cell activity in vitro
por: Zhou, Zailong, et al.
Publicado: (2019)

Gambogic Acid as a Candidate for Cancer Therapy: A Review
por: Liu, Yuling, et al.
Publicado: (2020)

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
por: O'Brien, Keith, et al.
Publicado: (2015)

TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis
por: Xu, Han, et al.
Publicado: (2023)

Inhibitory Effects of Rhein on Renal Interstitial Fibrosis via the SHH-Gli1 Signal Pathway
por: Luo, Yan, et al.
Publicado: (2022)

Gambogic acid inhibits growth, induces apoptosis, and overcomes drug resistance in human colorectal cancer cells
por: WEN, CHUANGYU, et al.
Publicado: (2015)

Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma
por: Caimano, Miriam, et al.
Publicado: (2021)

Preparation and anti-triple-negative breast cancer cell effect of a nanoparticle for the codelivery of paclitaxel and gemcitabine
por: Yang, Fan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ems7454kilrt3tjk5htr52knob